Low-gradient aortic stenosis (AS) comprises approximately half of severe AS cases, presenting a complex management scenario due to discrepancies in aortic valve area (AVA) and gradient, leading to uncertainty about the actual stenosis severity and the indication for aortic valve replacement (AVR) [ ]. Despite the elevated mortality rates for low-flow LG AS, multiple studies have consistently demonstrated a significant survival advantage for patients undergoing AVR as opposed to conservative management [ ]. A recent study from the TOPAS (True or Pseudo Severe Aortic Stenosis) found that transcatheter aortic valve replacement (TAVR) might be superior to surgical aortic valve replacement and conservative management for both classic and paradoxical low-flow LG AS [ ].